Principal Investors Private Equity (PIPE)
Because complex topics are a matter for consultants
Investing in the Future: Healthcare Life Sciences
Strongly growing, stable sector with high complexity
Healthcare, an attractive opportunity for investors. The industry is considered thoroughly regulated and less susceptible to economic fluctuations. Not least for this reason, the Healthcare Life Sciences sector in the DACH region is becoming increasingly attractive for investors and entrepreneurs. Especially the areas of Healthcare Providers, MedTech, and Pharma Services offer high potential for value enhancement and consolidation. Investors are taking advantage of the growth opportunities in the healthcare industry, which arise from the high degree of innovation in the industry, demographic change, and ongoing cost pressure.
Growth financing and succession planning are considered common financing occasions. Ensuring high-quality medical care for patients is also an important argument for why more and more investors are engaging in the healthcare market.
Relevant trends: Investments in outpatient medical care – to support the succession of medical practices, and in classic MedTech – to finance innovation geographical growth.
Current Challenges
In principle, the healthcare market is attractive. Regulation and long-term innovation cycles provide stability and, on average, decent profitability.
However, this also means a high level of complexity for an investor, which does not exist in other sectors; due to market regulations, economic dynamics function fundamentally differently. In addition, there are strong influences from technology and patents. Those who want to invest here need professional support from experienced specialists.
Our Solutions
We are the sector-focused specialist with excellent, detailed know-how of essential market trends, regulatory circumstances pitfalls, as well as relevant technological innovations. Through our many years of experience and our own successful entrepreneurial activity in the sector, we know how to master the challenges and achieve the full potential of a company.
We advise investors entrepreneurs in the provider, MedTech, pharma, and healthcare IT sectors. The size of the investment doesn’t matter to us. We see ourselves as a long-term, entrepreneurial partner throughout the entire lifecycle of an asset. We conduct market studies to define an initial investment thesis, undertake the review of business potential as part of commercial due diligence, and support value creation during the holding period.
Due Diligence
Detailed assessment of commercial and operational opportunities and risks based on deep sector expertise and proprietary access to experts decision-makers
Value Creation
Strategic results-oriented planning and implementation of entrepreneurial value creation
Market Studies
In-depth analysis of essential trends developments to determine the attractiveness of individual markets, as well as definition of well-founded market entry scenarios
Your Contacts
Philipp Stamm
Phone: +49 (0) 89 26 20 84 0 Email:
kontakt@wmc-healthcare.de
Burkhard Holz
Phone: +49 (0) 89 26 20 84 0 Email:
kontakt@wmc-healthcare.de